Literature DB >> 10438405

Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome.

M B Tíras1, R Yalcìn, V Noyan, I Maral, M Yìldìrìm, O Dörtlemez, S Daya.   

Abstract

The aim of this study was to examine the echocardiographic profiles of patients with polycystic ovarian syndrome (PCOS). Serum concentrations of follicle stimulating hormone, luteinizing hormone, androstenedione, free testosterone, prolactin, DHEA-SO(4) and 17-OH-progesterone, lipid profile (high and low density lipoproteins, triglyceride and total cholesterol) and basal and total insulin after a glucose tolerance test were measured in 35 patients with PCOS and 35 healthy controls matched for body mass index. Doppler, two dimensional M mode echocardiography was performed for the following indices: isovolumetric relaxation time (IVRT), E wave duration time (EVT), A wave duration time (AVT), E wave deceleration time (DT), peak early diastolic flow velocity (PEV), peak late diastolic flow velocity (PAV), E wave velocity time integral (FVI-E), A wave velocity time integral (FVI-A), atrial filling fraction (AFF), ejection fraction (EF), pre-ejection time (PEP), ejection time (ET) and aortic flow velocity time integral (FVI). Androstenedione, free testosterone, low density lipoproteins and cholesterol concentrations were significantly higher in patients with PCOS. There was no difference in basal and total insulin concentrations. IVRT, AVT, FVI-A, AFF, and PEP were higher in patients with PCOS, while PEV, FVI-E, EF, ET, EVT and EVT/AVT were higher in the control group. There was a positive correlation between basal insulin values and IVRT, and between total insulin values and EF. These changes are consistent with a non-restrictive type of diastolic dysfunction and left ventricular stiffness. PCOS may lead to diastolic dysfunction via hyperinsulinaemia and male type dyslipidaemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438405     DOI: 10.1093/humrep/14.8.1949

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  13 in total

1.  Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers.

Authors:  Sonali S Patel; Uyen Truong; Martina King; Annie Ferland; Kerrie L Moreau; Jennifer Dorosz; John E Hokanson; Hong Wang; Gregory L Kinney; David M Maahs; Robert H Eckel; Kristen J Nadeau; Melanie Cree-Green
Journal:  Vasc Med       Date:  2017-01-17       Impact factor: 3.239

2.  Polycystic ovary syndrome is associated with higher left ventricular mass index: the CARDIA women's study.

Authors:  Erica T Wang; Ivy A Ku; Sanjiv J Shah; Martha L Daviglus; Pamela J Schreiner; Suma H Konety; O Dale Williams; David Siscovick; Kirsten Bibbins-Domingo
Journal:  J Clin Endocrinol Metab       Date:  2012-09-25       Impact factor: 5.958

Review 3.  Cardiovascular complications of obesity in adolescents.

Authors:  F Orio; S Palomba; T Cascella; S Savastano; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  2007-01       Impact factor: 4.256

4.  The importance of speckle tracking echocardiography in the early detection of left ventricular dysfunction in patients with polycystic ovary syndrome.

Authors:  Selami Demirelli; Husnu Degirmenci; Emrah Ermis; Sinan Inci; Gokay Nar; Mehmet Emin Ayhan; Serdar Fırtına; Hikmet Hamur; Senay Arikan Durmaz
Journal:  Bosn J Basic Med Sci       Date:  2015-10-19       Impact factor: 3.363

5.  Hemodynamic alterations and wall properties in large arteries of young, normotensive, and non-obese women with polycystic ovary syndrome.

Authors:  E Trakakis; A Balanika; C Baltas; C Loghis; G Simeonidis; V Vaggopoulos; O Papakonstantinou; A Gouliamos; G Salamalekis; D Kassanos
Journal:  J Endocrinol Invest       Date:  2008-11       Impact factor: 4.256

Review 6.  Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.

Authors:  Krystallenia I Alexandraki; Eleni A Kandaraki; Kalliopi-Anna Poulia; Christina Piperi; Eirini Papadimitriou; Theodoros G Papaioannou
Journal:  touchREV Endocrinol       Date:  2021-04-28

7.  Rats with steroid-induced polycystic ovaries develop hypertension and increased sympathetic nervous system activity.

Authors:  Elisabet Stener-Victorin; Karolina Ploj; Britt-Mari Larsson; Agneta Holmäng
Journal:  Reprod Biol Endocrinol       Date:  2005-09-07       Impact factor: 5.211

Review 8.  Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women.

Authors:  Dinka Pavicic Baldani; Lana Skrgatic; Roya Ougouag
Journal:  Int J Endocrinol       Date:  2015-06-01       Impact factor: 3.257

9.  Atrial conduction time, and left atrial mechanical and electromechanical functions in patients with polycystic ovary syndrome: interatrial conduction delay.

Authors:  Emine Gazi; Meryem Gencer; Volkan Hanci; Ahmet Temiz; Burak Altun; Ahmet Barutcu; Ayse Nur Gungor; Servet Hacivelioglu; Ahmet Uysal; Yucel Colkesen
Journal:  Cardiovasc J Afr       Date:  2015 Nov-Dec       Impact factor: 1.167

10.  Effect of electro-acupuncture stimulation of different frequencies and intensities on ovarian blood flow in anaesthetized rats with steroid-induced polycystic ovaries.

Authors:  Elisabet Stener-Victorin; Rie Kobayashi; Orie Watanabe; Thomas Lundeberg; Mieko Kurosawa
Journal:  Reprod Biol Endocrinol       Date:  2004-03-26       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.